JAMES A. WELLS, PH.D.

Corporate Board Profile

Tech Score: 0/100

Viracta Therapeutics, Inc.

Filing Date	Source Excerpt
2008-04-29	Consistent with these considerations, after a review of all relevant transactions or relationships between each director, or any of his family members, and Sunesis, our senior management and our independent registered public accounting firm, the Board has affirmatively determined that Drs. Evnin, Fodor, Pearce and Stump and Messrs. Fust, Goldby and Leff, a majority of our Board, are independent directors within the meaning of the applicable NASDAQ listing requirements. ... We have entered into consulting agreements with Drs. Pearce, Stump and Wells for consulting services as described in more detail below. ... This amount reflects payments to Dr. Wells under his consulting agreement with us both for consulting services and for attending and serving as the chairman of a Scientific Advisory Board meeting in 2007.

Filing Date

Source Excerpt

2008-04-29

Consistent with these considerations, after a review of all relevant transactions or relationships between each director, or any of his family members, and Sunesis, our senior management and our independent registered public accounting firm, the Board has affirmatively determined that Drs. Evnin, Fodor, Pearce and Stump and Messrs. Fust, Goldby and Leff, a majority of our Board, are independent directors within the meaning of the applicable NASDAQ listing requirements. ... We have entered into consulting agreements with Drs. Pearce, Stump and Wells for consulting services as described in more detail below. ... This amount reflects payments to Dr. Wells under his consulting agreement with us both for consulting services and for attending and serving as the chairman of a Scientific Advisory Board meeting in 2007.

Data sourced from SEC filings. Last updated: 2026-03-09